Company Filing History:
3 out of 5,089 
2 out of 1,744 
2 out of 32 
Years Active: 2018-2022
Title: **Ariel Di Nardo: A Pioneer in Glycosaminoglycan Research**
Introduction
Ariel Di Nardo, an inventive researcher based in Palaiseau, France, has made significant contributions to the field of biomedicine through his innovative patents. With a solid background in his field, Di Nardo holds three patents that highlight his commitment to advancing medical science, particularly regarding nervous system-related pathologies.
Latest Patents
One of Di Nardo's notable patents focuses on the **ligand controlling interaction between glycosaminoglycans (GAGs) and their effector molecules**. This invention introduces new compounds that mimic glycosaminoglycans, which effectively manage the interactions between GAGs and their respective effector molecules. The peptides developed from this invention have the potential to prevent or reduce the binding of effector molecules to glycosaminoglycans. This groundbreaking approach could serve as a drug to stimulate neurogenesis and address various nervous system-related diseases.
Another of his significant inventions includes **methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide**. This patent outlines a method that involves delivering a polypeptide to Otx2 target cells by using a chimeric polypeptide. This method is groundbreaking as it harnesses a targeting peptide to facilitate the delivery of therapeutic molecules precisely where they are needed.
Career Highlights
Throughout his career, Ariel Di Nardo has collaborated with prestigious research institutions including the **Centre National de la Recherche Scientifique (CNRS)** and the **Institut National de la Santé et de la Recherche Médicale (INSERM)**. His work in these institutions has allowed him to refine his research skills and contribute to further advancements in medical research.
Collaborations
Di Nardo has also worked alongside esteemed colleagues in the field, such as Alain Prochiantz and Jean-Maurice Mallet. These collaborations have undoubtedly helped in honing his research endeavors and expanding the reach and impact of his innovative work.
Conclusion
Ariel Di Nardo stands out as a prolific inventor whose patents serve as significant milestones in the study of glycosaminoglycans and their application in medical treatments. His contributions not only showcase his inventive capabilities but also highlight the potential for these innovations to pave the way for future developments in treating nervous system-related disorders. As he continues to advance research in this vital area, the scientific community eagerly anticipates the impact of his future inventions.